Medicine and Dentistry
Patient
100%
Phlebothrombosis
80%
Inpatient
50%
Thromboprophylaxis
40%
Protein Tyrosine Kinase
40%
Prevalence
40%
Janus Kinase
40%
Myeloproliferative Disorder
40%
Risk Assessment
40%
Dentoalveolar Surgery
40%
Procoagulant
10%
Therapeutic Procedure
8%
Secondary Care
5%
Bleeding
5%
Health Care
5%
Drug Therapy
5%
Carer Health
5%
Experience
5%
Obstetric Delivery
5%
Platelet
5%
Thrombophilia
5%
Chronic Pancreatitis
5%
Somatic Mutation
5%
Allele
5%
Hematocrit
5%
Follow up
5%
Clinical Significance
5%
Umbilical Vein
5%
Cell Count
5%
Hemoglobin Determination
5%
Polymerase Chain Reaction
5%
Sepsis
5%
Nursing and Health Professions
Venous Thromboembolism
40%
Rivaroxaban
40%
Complication
16%
Clinical Practice
16%
Recurrent Disease
8%
Anticoagulation
8%
Follow up
8%
Screening
8%
Health Care Personnel
8%
Patient
8%
Postthrombosis Syndrome
8%
Clinical Outcome
8%
Odds Ratio
8%
Confidence Interval
8%
Drug Therapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
40%
Rivaroxaban
40%
Direct Oral Anticoagulant
40%
Venous Thromboembolism
8%
Bleeding
5%
Creatinine
5%
